Evidence map›Paper›PMID 37461634›Full record

ArticleResearch square2023

Simplified and Highly-reliable automated production of [18F]FSPG for clinical studies.

Mai Lin, Robert T Ta, H Charles Manning

Abstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Mai LinThe University of Texas MD Anderson Cancer Center.ORCID 0000-0003-0809-7129
Robert T TaThe University of Texas MD Anderson Cancer Center.
H Charles ManningThe University of Texas MD Anderson Cancer Center.

Funding

Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2019 to 2026
$19.6M
VU PREDICTU24CA220325 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KOPETZ, SCOTT, MANNING, HENRY CHARLES · 2018 to 2022
$3.3M
Quantitative PET Imaging of Hepatocellular Carcinoma (HCC)R01CA239694 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MANNING, HENRY CHARLES · 2020 to 2024
$2.3M
NCI NIH HHS P50 CA236733NCI NIH HHS R01 CA239694NCI NIH HHS U24 CA220325
6 · The paper itself

Abstract

Background (S)-4-(3-

Identifiers

PMID37461634
PMCPMC10350228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.